title: Felty's syndrome: long-term followup after treatment with auranofin.
abstract: Five patients who had Felty's syndrome were treated with auranofin, 6 mg/day, for a period that ranged from 4 months to 2 years. All patients experienced both an improvement in articular symptoms and a normalization of the leukocyte count. Auranofin appears to be an effective treatment for Felty's syndrome, and to have a lower degree of toxicity than parenteral gold.
authors: Second Department of Medicine, S. Maria Nuova Hospital, Reggio Emilia, Italy.
authors: A
authors: A
authors: Bellelli
authors: M
authors: M
authors: Veneziani
authors: B
authors: B
authors: Tumiati
mesh_terms: D000368:Aged; D001310:Auranofin / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004341:Drug Evaluation; D005258:Felty Syndrome / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D008875:Middle Aged; D013997:Time Factors
chemical_list: D001310:Auranofin